期刊文献+

人源肝细胞系CL-1、HepFMMU、HepG2、C3A生物学特性与功能的比较 被引量:2

Comparison of biological features and functions of human hepatocyte lines CL-1,HepFMMU,HepG2,and C3A
下载PDF
导出
摘要 目的:比较体外培养的四种人源肝细胞系CL-1、HepFMMU、HepG2、C3A生物学与功能特性的异同,初步评价其应用于生物人工肝的可行性,为其在组织工程学研究和临床医学中的应用奠定基础。方法:4种肝细胞在接种密度相同的条件下培养7d,观察4种细胞形态特征和功能状态,检测培养液中白蛋白、尿素及安定代谢量。结果:4种肝细胞系均具有较快的生长速度,功能学比较C3A具有良好的白蛋白合成和安定代谢功能;CL-1具有良好的尿素合成功能。结论:4种肝细胞具有良好的增殖能力,C3A具有良好的白蛋白合成及安定代谢能力,但其尿素合成能力较差,需进一步改进;CL-1具有较好的尿素合成能力,但其安定代谢和白蛋白合成功能较差;HepFMMU功能较差,不适宜用于生物人工肝。 Objective To evaluate the potential feasibility of using of human hepatocyte lines in bioartificial liver and tissue engineering by comparing their biological features and functions.Methods Four hepatocyte lines were cultured for seven days under the condition of the same density of the cells at the beginning,the characteristics of cell morphological were observed,the synthesis level of albumin,biotransformation of urea and the diazepam metabolism level were detected.Results Four human hepatocyte lines have same speed of growth,C3A has the best capacity of albumin synthesis and the diazepam metabolism;the urea concentration of CL-1 was the best among four hepatocytes.Conclusion Four hepatocyte lines have better capacity of proliferation;C3A has the best capacity of albumin synthesis and the diazepam metabolism,however it's biotransformation of urea was poor and need further improvement;CL-1 has the best urea biotransformation ability,but it's capacity of albumin synthesis and the diazepam metabolism was not good;the liver-specific function of HepFMMU was poor and not appropriate for bioartificial liver.
出处 《实用医学杂志》 CAS 北大核心 2012年第4期540-543,共4页 The Journal of Practical Medicine
基金 国家高技术研究发展计划(863计划)项目(编号:2006AA02A141) 广东省科技计划项目(编号:2007A032100005) 广东省自然科学基金项目(编号:07300180)
关键词 肝细胞 生物学特性 生物人工肝 Hepatocyte Biological feature Bioartificial liver
  • 相关文献

参考文献7

  • 1Streetz K L.Bio-artificial liver devices--tentative,but promising progress[J].J Hepatol,2008,48(2):189-191.
  • 2李浩,高毅,杨继震,薛国柱.中国人肝细胞系作为生物人工肝细胞材料的可行性探讨[J].中国临床康复,2004,8(2):240-241. 被引量:11
  • 3Ellis A J,Hughes R D,Wendon J A,et al.Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure[J].Hepatology,1996,24(6):1446-1451.
  • 4李羽,白雪帆,王军,徐哲,张岩.永生化胚胎肝细胞系的构建及其生物学特性[J].第四军医大学学报,2006,27(11):971-974. 被引量:8
  • 5Chamuleau R A,Deurholt T,Hoekstra R.which are the right cells to be used in a bioartificial liver[J].Metab Brain Dis,2005,20(4):327-335.
  • 6Ono S,Hatanaka T,Miyazawa S,et al.Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s:role of CYP286,2C19 and the 3A subfamily[J].Xenobiotica,1996,26(11):1155-1166.
  • 7Morgan E T.Regulation of cytochromes P450 during inflammation and infection[J].Drug Metab Rev,1997,29(4):1129-1188.

二级参考文献16

  • 1Di Campli C,Gasbarrini G,Gasbarrini A.A medicine based on cell transplantation -is there a future for treating liver diseases?[J].Aliment Pharmacol Ther,2003,18:473-480.
  • 2Di Campli C,Nestola M,Piscaglia AC,et al.Cell-based therapy for liver diseases[J].Eur Rev Med Pharmacol Sci,2003,7:41-44.
  • 3Leckel K,Blaheta RA,Markus BH.State of hepatocyte transplantation:A risk or a chance?[J].Zentralbl Chir,2003,128:283-290.
  • 4Strain AJ,Neuberger.A bioartificial liver-state of the art[J].Science,2002,295(8):1005-1009.
  • 5Ichida T.Artificial liver support system for fulminant hepatic failure as bridge-use to living donor liver transplantation[J].Intern Med,2003,42(10):920-921.
  • 6Kobayashi N,Okitsu T,Tanaka N.Cell choice for bioartificial livers[J].Keio J Med,2003,52(3):151-157.
  • 7Kerkhove MP,Hoekstra R,Chamuleau RA,et al.Clinical application of bioartificial liver support systems[J].Ann Surg,2004,240(2):216-230.
  • 8Xu Q,Sun X,Qiu Y,et al.The optimal hepatocyte density for a hollow-fiber bioartificial liver[J].Ann Clin Lab Sci,2004,34(1):87-93.
  • 9Hodgson H.Liver cells:biology to therapeutics[J].Clin Med,2003,3:161-165.
  • 10Tacke S,Bodusch K,Berg A,et al.Sensitive and specific detection methods for porcine endogenous retrovirus applicable to experimental and clinical xenotransplantation[J].Xenotransplantation,2001,8:125-135.

共引文献15

同被引文献5

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部